Global Kaposi Sarcoma Market by Type, Drug Class, Treatment, Mode of Treatment - Forecast 2024-2030- Product Image

Sale

Global Kaposi Sarcoma Market by Type, Drug Class, Treatment, Mode of Treatment - Forecast 2024-2030

Report
195 Pages
March 2024
Region: Global
360iResearch™
ID: 5888876

UP TO €846EUR$875USD£717GBP OFF until Dec 31^st 2024

The Kaposi Sarcoma Market size was estimated at USD 140.29 million in 2023, USD 145.55 million in 2024, and is expected to grow at a CAGR of 3.73% to reach USD 181.40 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Kaposi Sarcoma Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Kaposi Sarcoma Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Kaposi Sarcoma Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Amneal Pharmaceuticals LLC, Aphios Corporation, Aurobindo Pharma Limited, Bausch Health Companies Inc., Baxter International, Inc., Bayer AG, Bristol-Myers Squibb Company, Celgene Corporation, Cipla Limited, Eli Lilly and Company, F. Hoffmann-La Roche AG, Getwell Oncology Pvt Ltd, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, John Wiley & Sons, Inc., Johnson & Johnson Services, Inc, Lupin Ltd., Merck & Co., Inc, Mylan N.V., Navidea Biopharmaceuticals, Inc., Pfizer Inc., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.

Market Segmentation & Coverage

This research report categorizes the Kaposi Sarcoma Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Classic (Mediterranean) Kaposi Sarcoma
- Endemic (African) Kaposi Sarcoma
- Epidemic (AIDS-associated) Kaposi Sarcoma
- Iatrogenic (Transplant-Related) Kaposi Sarcoma
Drug Class
- Doxil (Doxorubicin Hydrochloride Liposome)
- Doxorubicin Hydrochloride Liposome
- Intron A (Recombinant Interferon Alfa-2b)
- Paclitaxel
- Pomalidomide
- Pomalyst (Pomalidomide)
- Recombinant Interferon Alfa-2b
- Vinblastine Sulfate
Treatment
- Biological Therapy
- Chemotherapy
- Cryosurgery
- HAART
- Radiation Therapy
- Surgery
- Treatment
Mode of Treatment
- Chemotherapy
- Intralesional Injection

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Kaposi Sarcoma Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Kaposi Sarcoma Market?
What are the technology trends and regulatory frameworks in the Kaposi Sarcoma Market?
What is the market share of the leading vendors in the Kaposi Sarcoma Market?
Which modes and strategic moves are suitable for entering the Kaposi Sarcoma Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Kaposi Sarcoma Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of HIV-associated Kaposi Sarcoma
5.1.1.2. Rising number of patients undergoing organ transplantation procedures
5.1.1.3. Growing number of clinical studies related to Kaposi Sarcoma disease
5.1.2. Restraints
5.1.2.1. High cost associated with diagnosis of Kaposi Sarcoma treatment
5.1.3. Opportunities
5.1.3.1. Investment in R&D activities for Kaposi Sarcoma treatment
5.1.3.2. Introduction of advanced highly active antiretroviral treatment
5.1.4. Challenges
5.1.4.1. Lack of skilled workforce and shortage in the supply of drugs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Kaposi Sarcoma Market, by Type

6.1. Introduction
6.2. Classic (Mediterranean) Kaposi Sarcoma
6.3. Endemic (African) Kaposi Sarcoma
6.4. Epidemic (AIDS-associated) Kaposi Sarcoma
6.5. Iatrogenic (Transplant-Related) Kaposi Sarcoma

7. Kaposi Sarcoma Market, by Drug Class

7.1. Introduction
7.2. Doxil (Doxorubicin Hydrochloride Liposome)
7.3. Doxorubicin Hydrochloride Liposome
7.4. Intron A (Recombinant Interferon Alfa-2b)
7.5. Paclitaxel
7.6. Pomalidomide
7.7. Pomalyst (Pomalidomide)
7.8. Recombinant Interferon Alfa-2b
7.9. Vinblastine Sulfate

8. Kaposi Sarcoma Market, by Treatment

8.1. Introduction
8.2. Biological Therapy
8.3. Chemotherapy
8.4. Cryosurgery
8.5. HAART
8.6. Radiation Therapy
8.7. Surgery
8.8. Treatment

9. Kaposi Sarcoma Market, by Mode of Treatment

9.1. Introduction
9.2. Chemotherapy
9.3. Intralesional Injection

10. Americas Kaposi Sarcoma Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Kaposi Sarcoma Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Kaposi Sarcoma Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. AbbVie Inc.
14.1.3. Amneal Pharmaceuticals LLC
14.1.4. Aphios Corporation
14.1.5. Aurobindo Pharma Limited
14.1.6. Bausch Health Companies Inc.
14.1.7. Baxter International, Inc.
14.1.8. Bayer AG
14.1.9. Bristol-Myers Squibb Company
14.1.10. Celgene Corporation
14.1.11. Cipla Limited
14.1.12. Eli Lilly and Company
14.1.13. F. Hoffmann-La Roche AG
14.1.14. Getwell Oncology Pvt Ltd
14.1.15. GlaxoSmithKline PLC
14.1.16. Hikma Pharmaceuticals PLC
14.1.17. John Wiley & Sons, Inc.
14.1.18. Johnson & Johnson Services, Inc
14.1.19. Lupin Ltd.
14.1.20. Merck & Co., Inc
14.1.21. Mylan N.V.
14.1.22. Navidea Biopharmaceuticals, Inc.
14.1.23. Pfizer Inc.
14.1.24. Sun Pharmaceutical Industries Ltd.
14.1.25. Teva Pharmaceutical Industries Ltd.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. KAPOSI SARCOMA MARKET RESEARCH PROCESS
FIGURE 2. KAPOSI SARCOMA MARKET SIZE, 2022 VS 2030
FIGURE 3. KAPOSI SARCOMA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. KAPOSI SARCOMA MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. KAPOSI SARCOMA MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. KAPOSI SARCOMA MARKET DYNAMICS
FIGURE 7. KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 8. KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2022 VS 2030 (%)
FIGURE 10. KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
FIGURE 12. KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2022 VS 2030 (%)
FIGURE 14. KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS KAPOSI SARCOMA MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS KAPOSI SARCOMA MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES KAPOSI SARCOMA MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES KAPOSI SARCOMA MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC KAPOSI SARCOMA MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC KAPOSI SARCOMA MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA KAPOSI SARCOMA MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA KAPOSI SARCOMA MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. KAPOSI SARCOMA MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. KAPOSI SARCOMA MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. KAPOSI SARCOMA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. KAPOSI SARCOMA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL KAPOSI SARCOMA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. KAPOSI SARCOMA MARKET SIZE, BY CLASSIC (MEDITERRANEAN) KAPOSI SARCOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. KAPOSI SARCOMA MARKET SIZE, BY ENDEMIC (AFRICAN) KAPOSI SARCOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. KAPOSI SARCOMA MARKET SIZE, BY EPIDEMIC (AIDS-ASSOCIATED) KAPOSI SARCOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. KAPOSI SARCOMA MARKET SIZE, BY IATROGENIC (TRANSPLANT-RELATED) KAPOSI SARCOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 11. KAPOSI SARCOMA MARKET SIZE, BY DOXIL (DOXORUBICIN HYDROCHLORIDE LIPOSOME), BY REGION, 2018-2030 (USD MILLION)
TABLE 12. KAPOSI SARCOMA MARKET SIZE, BY DOXORUBICIN HYDROCHLORIDE LIPOSOME, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. KAPOSI SARCOMA MARKET SIZE, BY INTRON A (RECOMBINANT INTERFERON ALFA-2B), BY REGION, 2018-2030 (USD MILLION)
TABLE 14. KAPOSI SARCOMA MARKET SIZE, BY PACLITAXEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. KAPOSI SARCOMA MARKET SIZE, BY POMALIDOMIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. KAPOSI SARCOMA MARKET SIZE, BY POMALYST (POMALIDOMIDE), BY REGION, 2018-2030 (USD MILLION)
TABLE 17. KAPOSI SARCOMA MARKET SIZE, BY RECOMBINANT INTERFERON ALFA-2B, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. KAPOSI SARCOMA MARKET SIZE, BY VINBLASTINE SULFATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 20. KAPOSI SARCOMA MARKET SIZE, BY BIOLOGICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. KAPOSI SARCOMA MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. KAPOSI SARCOMA MARKET SIZE, BY CRYOSURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. KAPOSI SARCOMA MARKET SIZE, BY HAART, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. KAPOSI SARCOMA MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. KAPOSI SARCOMA MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 28. KAPOSI SARCOMA MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. KAPOSI SARCOMA MARKET SIZE, BY INTRALESIONAL INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS KAPOSI SARCOMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 43. CANADA KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. CANADA KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 45. CANADA KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 46. CANADA KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 47. MEXICO KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 49. MEXICO KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 50. MEXICO KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES KAPOSI SARCOMA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC KAPOSI SARCOMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 65. CHINA KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. CHINA KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 67. CHINA KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 68. CHINA KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 69. INDIA KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. INDIA KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 71. INDIA KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 72. INDIA KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 73. INDONESIA KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 75. INDONESIA KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 77. JAPAN KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. JAPAN KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 79. JAPAN KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 80. JAPAN KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 81. MALAYSIA KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. MALAYSIA KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 83. MALAYSIA KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 84. MALAYSIA KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 85. PHILIPPINES KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. PHILIPPINES KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 87. PHILIPPINES KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 88. PHILIPPINES KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 89. SINGAPORE KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. SINGAPORE KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 91. SINGAPORE KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. SINGAPORE KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 93. SOUTH KOREA KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. SOUTH KOREA KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 95. SOUTH KOREA KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 96. SOUTH KOREA KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 97. TAIWAN KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. TAIWAN KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 99. TAIWAN KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 100. TAIWAN KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 101. THAILAND KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. THAILAND KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 103. THAILAND KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 104. THAILAND KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 105. VIETNAM KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. VIETNAM KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 107. VIETNAM KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 108. VIETNAM KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA KAPOSI SARCOMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 114. DENMARK KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. DENMARK KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 116. DENMARK KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 117. DENMARK KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 118. EGYPT KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. EGYPT KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 120. EGYPT KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 121. EGYPT KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 122. FINLAND KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. FINLAND KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 124. FINLAND KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 125. FINLAND KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 126. FRANCE KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. FRANCE KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 128. FRANCE KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 129. FRANCE KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 130. GERMANY KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. GERMANY KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 132. GERMANY KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 133. GERMANY KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 134. ISRAEL KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. ISRAEL KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 136. ISRAEL KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 137. ISRAEL KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 138. ITALY KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. ITALY KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 140. ITALY KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 141. ITALY KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 144. NETHERLANDS KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 146. NIGERIA KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. NIGERIA KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 148. NIGERIA KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 149. NIGERIA KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 150. NORWAY KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. NORWAY KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 152. NORWAY KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 153. NORWAY KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 154. POLAND KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 155. POLAND KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 156. POLAND KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 157. POLAND KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 158. QATAR KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. QATAR KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 160. QATAR KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 161. QATAR KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 174. SPAIN KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. SPAIN KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 176. SPAIN KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 177. SPAIN KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 182. SWITZERLAND KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. SWITZERLAND KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 184. SWITZERLAND KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 185. SWITZERLAND KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 186. TURKEY KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 187. TURKEY KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 188. TURKEY KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 189. TURKEY KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM KAPOSI SARCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM KAPOSI SARCOMA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM KAPOSI SARCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM KAPOSI SARCOMA MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 198. KAPOSI SARCOMA MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 199. KAPOSI SARCOMA MARKET SHARE, BY KEY PLAYER, 2022
TABLE 200. KAPOSI SARCOMA MARKET LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
AbbVie Inc.
Amneal Pharmaceuticals LLC
Aphios Corporation
Aurobindo Pharma Limited
Bausch Health Companies Inc.
Baxter International, Inc.
Bayer AG
Bristol-Myers Squibb Company
Celgene Corporation
Cipla Limited
Eli Lilly and Company
F. Hoffmann-La Roche AG
Getwell Oncology Pvt Ltd
GlaxoSmithKline PLC
Hikma Pharmaceuticals PLC
John Wiley & Sons, Inc.
Johnson & Johnson Services, Inc
Lupin Ltd.
Merck & Co., Inc
Mylan N.V.
Navidea Biopharmaceuticals, Inc.
Pfizer Inc.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	195
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 145.55 Million
Forecasted Market Value ( USD ) by 2030	$ 181.4 Million
Compound Annual Growth Rate	3.7%
Regions Covered	Global
No. of Companies Mentioned	25

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3263EUR$3,374USD£2,763GBP €3625EUR$3,749USD£3,070GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4133EUR$4,274USD£3,500GBP €4593EUR$4,749USD£3,889GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5004EUR$5,174USD£4,238GBP €5560EUR$5,749USD£4,708GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5874EUR$6,074USD£4,975GBP €6527EUR$6,749USD£5,527GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7615EUR$7,874USD£6,449GBP €8461EUR$8,749USD£7,165GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Kaposi Sarcoma Market by Type, by Treatment, by End-Users, and By Region

Global Kaposi Sarcoma Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

Soft Tissue Sarcoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

Synovial Sarcoma Market Report and Forecast 2024-2032

AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2024

About the Market